Primary |
Dry Mouth |
66.7% |
Oral Lichen Planus |
33.3% |
|
Thermal Burn |
25.0% |
Throat Irritation |
25.0% |
Tremor |
25.0% |
Weight Decreased |
25.0% |
|
Secondary |
Atrial Fibrillation |
16.2% |
Anxiety |
10.8% |
Rheumatoid Arthritis |
10.8% |
Dyspepsia |
8.1% |
Smoking Cessation Therapy |
8.1% |
Bladder Disorder |
5.4% |
Blood Cholesterol Increased |
5.4% |
Dry Mouth |
5.4% |
Product Used For Unknown Indication |
5.4% |
Squamous Cell Carcinoma |
5.4% |
Supplementation Therapy |
5.4% |
Gastric Ulcer |
2.7% |
Hypertension |
2.7% |
Migraine |
2.7% |
Multiple Allergies |
2.7% |
Panic Attack |
2.7% |
|
Vomiting |
25.0% |
Depressed Mood |
12.5% |
Drug Ineffective |
12.5% |
Gastric Haemorrhage |
12.5% |
Stress |
12.5% |
Treatment Noncompliance |
12.5% |
Weight Decreased |
12.5% |
|
Concomitant |
Product Used For Unknown Indication |
50.3% |
Acute Myeloid Leukaemia |
10.1% |
Supplementation Therapy |
4.9% |
Prophylaxis |
4.0% |
Breast Cancer |
3.5% |
Pain |
3.1% |
Hypertension |
2.9% |
Non-small Cell Lung Cancer |
2.9% |
Constipation |
2.8% |
Drug Use For Unknown Indication |
2.4% |
Anxiety |
2.2% |
Chemotherapy |
1.6% |
Metastatic Pain |
1.4% |
Rheumatoid Arthritis |
1.4% |
Osteoporosis |
1.3% |
Atrial Fibrillation |
1.2% |
Diarrhoea |
1.2% |
Intravenous Catheter Management |
1.0% |
Medical Diet |
1.0% |
Nausea |
1.0% |
|
White Blood Cell Count Abnormal |
9.9% |
Tooth Extraction |
9.0% |
Vomiting |
7.2% |
Weight Decreased |
7.2% |
Fatigue |
6.3% |
Tooth Fracture |
6.3% |
Wheelchair User |
6.3% |
Wrist Fracture |
6.3% |
Dyspnoea |
5.4% |
Stomatitis |
5.4% |
White Blood Cell Count Decreased |
5.4% |
Pneumonia |
4.5% |
Sepsis |
3.6% |
Pyrexia |
2.7% |
Rash |
2.7% |
Sepsis Syndrome |
2.7% |
Spinal Osteoarthritis |
2.7% |
Urinary Retention |
2.7% |
Chest Discomfort |
1.8% |
Cholecystitis |
1.8% |
|
Interacting |
Anticoagulant Therapy |
14.6% |
Gastrooesophageal Reflux Disease |
14.6% |
Gout |
14.6% |
Blood Pressure |
12.4% |
Dental Care |
11.2% |
Dry Mouth |
11.2% |
Tachycardia |
11.2% |
Nausea |
4.5% |
Heart Rate Irregular |
3.4% |
Blood Pressure Management |
2.2% |
|
|